Palliation of allograft vasculopathy with transluminal angioplasty - A decade of experience

被引:72
作者
Benza, RL
Zoghbi, GJ
Tallaj, J
Brown, R
Kirklin, JK
Hubbard, M
Rayburn, B
Foley, B
McGiffin, DC
Pinderski, LJ
Misra, V
Bourge, RC
机构
[1] Univ Alabama, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA
[2] Birmingham VA Med Ctr, Dept Med, Birmingham, AL USA
[3] Univ Alabama, Dept Surg, Div Cardiovasc Surg, Birmingham, AL 35294 USA
关键词
D O I
10.1016/j.jacc.2004.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The goal of this study was to examine the outcomes of percutaneous coronary interventions (PCI) and the predictors for restenosis after cardiac transplantation. BACKGROUND The role of PCI as definitive therapy for allograft coronary disease (ACD) remains contentious. METHODS Between January 1, 1990 and December 31, 2000, 62 patients (1.5 to 15.5 years after transplant) underwent 151 procedures resulting in PCIs of 219 lesions. Follow-up after PCI angiography was usually obtained at three and six months, then yearly. Repeat PCI was routinely done to lesions with >60% restenosis. RESULTS The primary procedural success was 97%. Repeat PCI occurred in 74 of 219 lesions (34%); PCI-related mortality was 2.6% (4 of 151). The freedom from re-PCI (of same vessel site) was 75% at six months, 65% at one year, and 57% at four years. The freedom from restenosis was 95% at one month, 81% at three months, and 57% at six months. Multivariate predictors of freedom from restenosis were the use of stents, higher anti-proliferative immunosuppressant dose, and an era effect. In the setting of one-vessel disease at first PCI, the two-year freedom for ACD death or graft loss was 74%, compared. with 75% for two-vessel and 27% for three-vessel disease (p = 0.009). CONCLUSIONS Despite the increasing effectiveness of PCI for localized ACD, the survival after development of advanced ACD remains poor. Stents appear to increase effectiveness of PCI for ACD, but other factors in the current era contribute to improved outcomes. (C) 2004 by the American College of Cardiology Foundation.
引用
收藏
页码:1973 / 1981
页数:9
相关论文
共 41 条
[31]   The role of percutaneous transluminal coronary angioplasty in heart transplant recipients [J].
Schnetzler, B ;
Drobinski, G ;
Dorent, R ;
Camproux, AC ;
Ghossoub, JJ ;
Thomas, D ;
Gandjbakhch, I .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (06) :557-565
[32]   A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents [J].
Schomig, A ;
Neumann, FJ ;
Kastrati, A ;
Schuhlen, H ;
Blasini, R ;
Hadamitzky, M ;
Walter, H ;
ZitzmannRoth, EM ;
Richardt, G ;
Alt, E ;
Schmitt, C ;
Ulm, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (17) :1084-1089
[33]   A COMPARISON OF BALLOON-EXPANDABLE-STENT IMPLANTATION WITH BALLOON ANGIOPLASTY IN PATIENTS WITH CORONARY-ARTERY DISEASE [J].
SERRUYS, PW ;
DEJAEGERE, P ;
KIEMENEIJ, F ;
MACAYA, C ;
RUTSCH, W ;
HEYNDRICKX, G ;
EMANUELSSON, H ;
MARCO, J ;
LEGRAND, V ;
MATERNE, P ;
BELARDI, J ;
SIGWART, U ;
COLOMBO, A ;
GOY, JJ ;
VANDENHEUVEL, P ;
DELCAN, J ;
MOREL, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :489-495
[34]   Coronary angioplasty and stenting in orthotopic heart transplants: A fruitful act or a futile attempt? [J].
Sharifi, M ;
Siraj, Y ;
O'Donnell, J ;
Pompili, VJ .
ANGIOLOGY, 2000, 51 (10) :809-815
[35]   ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines) - Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) - Endorsed by the Society for Cardiac Angiography and Interventions [J].
Smith, SC ;
Dove, JT ;
Jacobs, AK ;
Kennedy, JW ;
Kereiakes, D ;
Kern, MJ ;
Kuntz, RE ;
Popma, JJ ;
Schaff, HV ;
Williams, DO ;
Gibbons, RJ ;
Alpert, JP ;
Eagle, KA ;
Faxon, DP ;
Fuster, V ;
Gardner, TJ ;
Gregoratos, G ;
Russell, RO .
CIRCULATION, 2001, 103 (24) :3019-3041
[36]  
Suwaidi Jassim Al, 2000, JAMA (Journal of the American Medical Association), V284, P1828
[37]   CORONARY ANGIOPLASTY IN CARDIAC TRANSPLANT RECIPIENTS [J].
SWAN, JW ;
NORELL, M ;
YACOUB, M ;
MITCHELL, AG ;
ILSLEY, C .
EUROPEAN HEART JOURNAL, 1993, 14 (01) :65-70
[38]  
VONSCHEIDT W, 1995, TRANSPLANT P, V27, P1936
[39]   Trends in outcome and costs of coronary intervention in the 1990s [J].
Weintraub, WS ;
Mahoney, EM ;
Ghazzal, ZMB ;
King, SB ;
Culler, SD ;
Morris, DC ;
Douglas, JS .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (05) :497-503
[40]  
Williams DO, 2000, CIRCULATION, V102, P2945